Financial Strain for Users of Long-Acting Contraceptives Under Employer-Sponsored Insurance
A recent analysis highlights the out-of-pocket expenses faced by individuals using IUDs and contraceptive implants, raising concerns about affordability in employer-sponsored insurance plans.
A study published in the journal Contraception examines the financial burdens associated with intrauterine devices (IUDs) and contraceptive implants for those enrolled in employer-sponsored insurance.
Conducted by KFF researchers Linda Li, Brittni Frederiksen, and Alina Salganicoff, the analysis reveals significant costs related to the insertion of these long-acting reversible contraceptives.
The findings underscore the need for further scrutiny of healthcare costs and accessibility for contraceptive methods within the framework of employer-sponsored insurance.